Biotechnology

Filter

Current filters:

None

Popular Filters

1910 to 1934 of 2115 results

Actelion posts 85.6 Swiss franc loss for first nine months of 2011

20-10-2011

Switzerland-based Actelion (ATLN: VX) recorded an operating loss of 85.6 million Swiss francs ($95.5…

ActelionBiotechnologyFinancial

Early treatment with Biogen and Elan’s Tysabri reduces MS relapse rates

19-10-2011

US biotech firm Biogen Idec (Nasdaq: BIIB) and Ireland-based Elan Corp (NYSE: ELN) have released new…

Biogen IdecBiotechnologyElanImmunologicalsNeurologicalPharmaceuticalResearchTysabri

Lux Biosciences withdraws European marketing application for uveitis drug Luveniq

19-10-2011

The European Medicines Agency has been formally notified by the European subsidiary of USA-based biotech…

BiotechnologyEuropeLuveniqLux BiosciencesOphthalmicsPharmaceuticalRegulation

Australian coalition government announces A$55 million commitment to biotechnology

18-10-2011

Australia’s Minister for Technology, Gordon Rich-Phillips this week released a new A$55 million…

Asia-PacificBiotechnologyFinancialPoliticsResearch

GlaxoSmithKline may be ready to acquire Human Genome, newspaper reports

18-10-2011

Shares of the UK’s biggest pharmaceuticals group, GlaxoSmithKline (LSE: GSK) amid revived speculation…

BenlystaBiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Angel Biotech proposes joint venture with Russia’s Materia Medica

18-10-2011

Scotland-based Angel Biotechnology (ABH: LON) saw its shares leap 20% to 0.28 pence on Monday after it…

Angel BiotechnologyBiotechnologyEuropeMateria MedicaMergers & Acquisitions

Epizyme earns $4 million pre-clinical milestone from GSK under novel HMT therapeutics alliance

17-10-2011

Privately-held US biotech startup Epizyme says it has achieved a pre-clinical milestones in its alliance…

BiotechnologyEpizymeFinancialGlaxoSmithKlineLicensingOncologyPharmaceutical

Sinovac awarded contract to supply Anflu flu vaccine to Beijing CDC

16-10-2011

Chinese biopharmaceuticals company Sinovac Biotech (Nasdaq: SVA) saw its share price jump 12% to $2.49…

AnfluAsia-PacificBiotechnologyMarkets & MarketingSinovacVaccines

German pharma hails progress against heart disease and rheumatism

13-10-2011

Cardiovascular disease is the most common cause of death in Germany, with 60,000 people dying of a heart…

Anti-Arthritics/RheumaticsBiotechnologyCardio-vascularEuropePharmaceuticalResearch

EMA launches database of clinical studies in children

12-10-2011

The European Medicines Agency has published a new database containing information on studies of medicines…

BiotechnologyEuropePharmaceuticalRegulationResearch

GlycoMimetics could earn $340 million from Pfizer in rare disease drug licensing deal

12-10-2011

Global drugs behemoth Pfizer (NYSE: PFE) has made another foray into the rare disease therapy sector,…

BiotechnologyGlycoMimeticsLicensingPfizerPharmaceuticalRare diseases

US FDA flexible in reviewing therapies for rare diseases, NORD study concludes

11-10-2011

The US National Organization for Rare Disorders (NORD) yesterday released a landmark report documenting…

BiotechnologyNorth AmericaPharmaceuticalRare diseasesRegulation

Insmed tumbles as FDA continues hold on Ph III Arikace trial

11-10-2011

US biopharmaceutical company Insmed (Nasdaq CM: INSM) saw its share price plunge 32% to $2.95 in morning…

ArikaceBiotechnologyInsmedNorth AmericaPharmaceuticalRegulationResearchRespiratory and Pulmonary

EMIG calls for action to build growth in the UK speciality biopharma sector

11-10-2011

The UK Ethical Medicines Industry Group (EMIG) has called for government, the National Health Service,…

BiotechnologyEuropeFinancialPharmaceuticalPoliticsResearch

FDA Commissioner outlines steps to spur biomedical innovation in USA

06-10-2011

A blueprint containing immediate steps that can be taken to drive biomedical innovation, while improving…

BiotechnologyNorth AmericaPharmaceuticalRegulationResearch

US biotech sector besieged by debt worries, political dysfunction in 3rd-qtr, says Burrill

06-10-2011

The fight in the USA over the raising of the debt ceiling and the debt crisis in Europe have fueled turmoil…

BiotechnologyFinancialMergers & AcquisitionsNorth AmericaRegulation

US Senators Grassley and Kohl urge action on Sunshine Law regarding industry relations with physicians

04-10-2011

US Senators Chuck Grassley (Republican, Iowa) and Herb Kohl (Democrat, Wisconsin) are pressing the Centers…

BiotechnologyNorth AmericaPharmaceuticalPoliticsRegulation

Contract research firm PPD to go private in $3.9 billion acquisition

04-10-2011

USA-based contact research organization Pharmaceutical Product Development (Nasdaq: PPDI) says it has…

BiotechnologyMergers & AcquisitionsPharmaceuticalPPD

EU invests 30 million euros to understand the epigenome

03-10-2011

The European Union has invested 30 million euros ($40.3 million) to understand the epigenome - a link…

BiotechnologyEuropeFinancialHealthcarePharmaceuticalResearch

Key considerations for successful biosimilar development viewed by Quintiles

03-10-2011

Regulatory and commercial considerations are the primary drivers for successful biosimilar clinical development,…

BiotechnologyGenericsGlobalQuintilesRegulationResearch

Intellect Neurosciences grants ViroPharma a license to OX1 in $126.5 million deal

03-10-2011

USA-based Intellect Neurosciences (OTCBB: ILNS.PK) has granted an exclusive license to US biotech firm…

BiotechnologyIntellect NeuroscienceLicensingPharmaceuticalRare diseasesViroPharma

1910 to 1934 of 2115 results

Back to top